Inventor · disambiguated record
Claire Williams
Also filed as: WILLIAMS CLAIRE
12 granted patents·5 pending applications·344 citations·filing 2010–2023
93Inventor score
Files withGW PHARMA LTD8GW RES LTD3WHALLEY BEN3JAZZ PHARMACEUTICALS RESEARCH UK LTD2WHALLEY BENJAMIN1
Top patents by PatentIndex Score
17 records- 0198US9522123B2Use of one or a combination of phyto-cannabinoids in the treatment of epilepsyGW PHARMA LTD·Filed 2014·Granted Dec 20, 2016·62 cites·13 claims
- 0297US11318109B2Pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD)GW PHARMA LTD·Filed 2019·Granted May 3, 2022·17 cites·42 claims
- 0396US12121499B2Pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD)GW PHARMA LTD·Filed 2022·Granted Oct 22, 2024·3 cites·22 claims
- 0496US12023305B2Use of the phytocannabinoid cannabidivarin (CBDV) in the treatment of epilepsyGW PHARMA LTD·Filed 2020·Granted Jul 2, 2024·9 cites·7 claims
- 0596US11793770B27-OH-cannabidiol (7-OH-CBD) and/or 7-OH-cannabidivarin (7-OH-CBDV) for use in the treatment of epilepsyGW RES LTD·Filed 2021·Granted Oct 24, 2023·18 cites·12 claims
- 0696US11147776B27-OH-cannabidiol (7-OH-CBD) and/or 7-OH-cannabidivarin (7-OH-CBDV) for use in the treatment of epilepsyGW RES LTD·Filed 2019·Granted Oct 19, 2021·33 cites·21 claims
- 0796US10799467B2Use of the phytocannabinoid cannabidivarin (CBDV) in the treatment of epilepsyGW PHARMA LTD·Filed 2015·Granted Oct 13, 2020·22 cites·6 claims
- 0896US9066920B2Use of one or a combination of phyto-cannabinoids in the treatment of epilepsyWHALLEY BEN·Filed 2010·Granted Jun 30, 2015·74 cites·13 claims
- 0995US12357586B2Use of the phytocannabinoid cannabidiol (CBD) in combination with a standard anti-epileptic drug (SAED) in the treatment of epilepsyJAZZ PHARMACEUTICALS RESEARCH UK LTD·Filed 2022·Granted Jul 15, 2025·2 cites·12 claims
- 1095US9125859B2Use of the phytocannabinoid cannabidivarin (CBDV) in the treatment of epilepsyWHALLEY BEN·Filed 2011·Granted Sep 8, 2015·77 cites·9 claims
- 1193US10729665B2Pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD)WHALLEY BENJAMIN·Filed 2012·Granted Aug 4, 2020·25 cites·11 claims
- 1286US12263139B2Use of cannabidiol in the treatment of tuberous sclerosis complexJAZZ PHARMACEUTICALS RESEARCH UK LTD·Filed 2023·Granted Apr 1, 2025·2 cites·22 claims
- 1361US2019247324A1One or a Combination of Phyto-Cannabinoids in the Treatment of EpilepsyGW PHARMA LTD·Filed 2018·Application pending·0 cites
- 1456US2017273913A1Use of one or a combination of phyto-cannabinoids in the treatment of epilepsyGW PHARMA LTD·Filed 2016·Application pending·0 cites
- 1555US2017209390A17-oh-cannabidiol (7-oh-cbd) and/or 7-oh-cannabidivarin (7-oh-cbdv) for use in the treatment of epilepsyGW PHARMA LTD·Filed 2015·Application pending·0 cites
- 1650US2020206153A1Use of cannabidiol in the treatment of tuberous sclerosis complexGW RES LTD·Filed 2018·Application pending·0 cites
- 1746US2014155456A9Use of the phytocannabinoid cannabidiol (cbd) in combination with a standard anti-epileptic drug (saed) in the treatment of epilepsyWHALLEY BEN·Filed 2012·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →